Posts tagged with licensing
Jo McEntyre, EMBL-EBI; Thomas Lemberger, EMBO; Mark Patterson, eLife; Kristen Rattan, Collaborative Knowledge Foundation; Alfonso Valencia, Barcelona Supercomputer Centre. The use of preprints in the life sciences offers tantalising opportunities to change the way research results are communicated and reused, and the work of ASAPbio has been key in engaging the scientific community to promote […]
Guest post from Alex Green, Transformation Project Co-ordinator, Wellcome Trust Last month saw the publication of the 2014 Taylor & Francis Open Access Survey. Combining responses from just over 7,900 authors who published with Taylor & Francis in 2012 (9% of the total), this represents the opinions of authors from across the world in roughly […]
On the 1st April 2013, both the Wellcome Trust and the Research Councils UK will require that any article which attributes their funding and incurs an Article Processing Charge (APC) must be licensed using the Creative Commons Attribution license (CC-BY). This blog posting provides an update as to those publishers who publish high volumes of […]
The British Journal of Cancer – owned by Cancer Research UK (CR-UK) – has chosen to implement the Creative Commons Attribution-NonCommercial-Share Alike 3.0 licence http://creativecommons.org/licenses/by-nc-sa/3.0/ for articles published under the BJC OPEN initiative. This licence permits distribution and reproduction in any medium, provided the original author and source are credited. The licence does not permit […]
Europe PMC is a service of the Europe PMC Funders' Group, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI); and in cooperation with the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NCBI/NLM) . It includes content provided to the PubMed Central (NLM/PMC) archive by participating publishers.